COMMISSION DECISION
of 20 December 2007
concerning a financial contribution from the Community towards a survey on the prevalence of
Salmonella
spp. and Methicillin-resistant
Staphylococcus aureus
in herds of breeding pigs to be carried out in the Member States
(notified under document number C(2007) 6579)
(2008/55/EC)
Article 1
Subject matter and scope
Article 2
Definition
Article 3
Scope of the surveys
Article 4
Performance of sampling and analyses
Article 5
Conditions for granting a Community financial contribution
Article 6
Maximum amounts to be reimbursed
Article 7
Collection of data, assessment and reporting
Article 8
Conversion rate for expenditure
Article 9
Repeal of Decision 2007/636/EC
Article 10
Application
Article 11
Addressees
ANNEX I
TECHNICAL SPECIFICATIONS REFERRED TO IN ARTICLE 3, ARTICLE 4 AND ARTICLE 5(2)(b)
Part A: Overview and sampling frame
1. Overview of the survey
Figure 1
Overview of the survey
2. Sampling frame
2.1. The delineation of the population
Figure 2
Overview of holdings
2.2. The sample and the sampling strategy
2.2.1. First stage: selection of holdings
2.2.2. Second stage: sampling on the holding
2.3. The sample size calculation
2.3.1. Primary sample size (first-stage sample size)
Number of holdings with breeding pigs (N) |
Sample size (n) for finite population size 7,5 % accuracy |
100 000 |
171 |
10 000 |
169 |
5 000 |
166 |
2 000 |
158 |
1 000 |
147 |
500 |
128 |
250 |
102 |
150 |
80 |
125 |
73 |
100 |
64 |
90 |
59 |
80 |
55 |
70 |
50 |
60 |
45 |
50 |
39 |
40 |
33 |
30 |
26 |
20 |
18 |
10 |
10 |
2.3.2. Secondary sample size (second-stage sample size)
Part B: Sample collection and analysis for the
Salmonella
survey
1. Sample collection in the herds
1.1. Type and detail of the routine sample
1.2. Additional sampling for the within-holding prevalence study
1.3. Sample information
1.4. Transport of samples
2. Laboratory analytical methods
2.1. Laboratories
2.2. Receipt of samples
2.3. Sample analysis
2.3.1. Preparation
2.3.2. Detection and identification methods
2.3.2.1. Detection of
Salmonella
2.3.2.2. Serotyping of
Salmonella
2.3.2.3. Phage typing of
Salmonella
Part C: Sample collection and analysis for the MRSA survey
1. Type and detail of sample
1.1. Sample collection
1.2. Sample information
1.3. Transport of samples
2. Laboratory analytical methods
2.1. Laboratories
2.2. Receipt of samples
2.3. Sample analysis
2.3.1. Selective enrichment
2.3.2. Identification of MRSA
2.3.3. Subtyping for possible link to human isolates
2.3.4. Antimicrobial susceptibility testing
2.4. Storage of isolates
3. Reporting from the laboratories
Part D: Reporting from the Member States
1. Overall description on the implementation of the
Salmonella
and MRSA surveys
2. Complete data on each holding sampled and corresponding tests results:
2.1. Information on the holding
2.2. Information on all samples collected within the Salmonella survey
2.3. Additional information on the samples collected within the Salmonella survey for the within holding prevalence
2.4. Information on the samples collected within the MRSA survey
ANNEX II
Member State |
Maximum total amount for co-financing of analyses (EUR) |
Belgium – BE |
74 003 |
Bulgaria – BG |
64 672 |
Czech republic – CZ |
120 621 |
Denmark – DK |
114 829 |
Germany – DE |
71 750 |
Estonia – EE |
11 583 |
Ireland – IE |
53 732 |
Greece – EL |
48 584 |
Spain – ES |
102 317 |
France – FR |
102 317 |
Italy – IT |
98 134 |
Cyprus – CY |
24 775 |
Latvia – LV |
4 183 |
Lithuania – LT |
17 053 |
Luxembourg – LU |
14 801 |
Hungary – HU |
92 021 |
Malta – MT |
0 |
Netherlands – NL |
107 786 |
Austria – AT |
73 037 |
Poland – PL |
105 212 |
Portugal – PT |
67 889 |
Romania – RO |
126 734 |
Slovenia – SI |
93 594 |
Slovakia – SK |
66 924 |
Finland – FI |
80 116 |
Sweden – SE |
93 594 |
United Kingdom – UK |
120 621 |
Total |
1 950 878 |
ANNEX III
CERTIFIED FINANCIAL REPORT ON THE IMPLEMENTATION OF THE BASELINE SURVEY ON THE PREVALENCE OF
SALMONELLA
SPP. AND MRSA IN HERDS OF BREEDING PIGS
Statement on costs incurred in the survey and eligible for Community financial contribution:
Costs incurred related to functions at/by |
Number of tests/swabs |
Total costs of testing and swabs incurred during the reporting period (national currency) |
Bacteriology for Salmonella spp. |
|
|
Serotyping Salmonella isolates |
|
|
Detection of MRSA |
|
|
Identifications of MRSA by PCR(s) |
|
|
Spa typing MRSA |
|
|
MLST typing MRSA |
|
|
Swabs for MRSA testing |
|
|